| Catalog No. |
Size |
Price |
Figures |
|---|
Z00107-1 mg
| 1 mg | $ 420.00 |
References:
- Beld M, et al. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology. Apr 1999; 29 (4): 1288-1298.
- Norder H, et al. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region. J. Clin. Microbiol. Oct 1998; 36 (10): 3066-3069.
- Neville JA, et al. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J. Clin. Microbiol. Dec 1997; 35 (12): 3062-3070.
|
|---|
| Full Name | | Hepatitis C Virus (HCV) NS5 Genotype 2 |
|
| Abbreviated Name-1 | Hepatitis NS5 G2 |
|---|
| Abbreviated Name-2 | rHCVNS5G2 |
|---|
| Description | E. coli-derived recombinant. The protein Hepatitis C Virus (HCV) NS5 Genotype 2 contains the HCV core immunodominant region. |
|---|
| Source | E. coli |
|---|
| Purity | Protein is >95% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 25 mM Tris-HCl, 1 mM EDTA, 1.5 M urea, 50% glycerol. |
|---|
| Stability | Five years frozen. One month in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of HCV-infected individuals, including sera with antibodies to NS3 secondary domains. |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HCV with minimal specificity problems. |
|---|
